Mental disorders in cancer patients - clinical approach
Journal Title: OncoReview - Year 2013, Vol 3, Issue 2
Abstract
Cancer patient is struggling not only with the primary disease, but also is exposed to emotional states that at unfavorable conditions and heavy burden can lead to depression, increased anxiety, and in consequence cause various mental disorders. Good cooperation between the medical oncologist and the patient, as well as medical oncologist with a psychiatrist and/or psychotherapist can help in the correct diagnosis of these disorders and the implementation of treatment tailored to the patient’s general state and the severity of these symptoms. The paper presents background information on depression and anxiety incancer patients as well as treatment options.
Authors and Affiliations
Anna Kieszkowska-Grudny
Terapia ewerolimusem u pacjenta z zaawansowanym nowotworem neuroendokrynnym trzustki – opis przypadku
Coraz częstsze występowanie nowotworów neuroendokrynnych przewodu pokarmowego jest spowodowane nie tylko rzeczywistym wzrostem zachorowalności, ale także postępem w zakresie ich diagnostyki. Właściwe rozpoznanie oraz oce...
Cisplatin-induced cardiotoxicity – two case reports
Cisplatin has been used for over 40 years in various cancer chemotherapies. Toxicity induced by cisplatin-based therapeutic regimens include gastrointestinal toxicity, myelotoxicity, neurotoxicity, ototoxicity and nephro...
Coronary angioplasty and aortic valve replecement in two patients with multiple myeloma - case reports
Multiple myeloma is a hematological disorder characterized by a clonal proliferation of atypical plasma cells, which produce a monoclonal immunoglobulin. The annual incidence rate in Europe is about 4.5/100 000 persons,...
Tumor lysis syndrome
Tumor lysis syndrome is a life-threatening oncological emergency occurring in response to chemotherapy or spontaneously as a result of massive and rapid breakdown of malignant cells. The release of their contents into ci...
Complications of palliative antiangiogenic therapy in patients with colorectal cancer
Introduction: Bevacizumab is an antiangiogenic drug used in the therapy of numerous solid tumours including colorectal adenocarcinoma. The efficacy and safety of bevacizumab has been demonstrated in many multicenter clin...